2-METHYL-N-(3-METHYL-4-((2,3,4,5-TETRAHYDRO-5-HYDROXY-1H-1-BENZAZEPIN-1-YL)CARBONYL)PHENYL)BENZAMIDE
UNII RN3YQF3BXV
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-methyl-n-(3-methyl-4-((2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl)carbonyl)phenyl)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RN3YQF3BXV.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1432725-23-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H26N2O3 TWKDOSHOLYKYDR-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-methyl-n-(3-methyl-4-((2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl)carbonyl)phenyl)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.